home All News open_in_new Full Article

PharmaCorp Rx Inc. Reports First Quarter 2025 Results and Announces Non

SASKATOON, Saskatchewan, May 29, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the filing on SEDAR+ of its unaudited financial statements together with associated MD&A for the first quarter ending March 31, 2025 as well as the execution of non-binding letters of intent to acquire four pharmacies. […]


today 2 w. ago attach_file Culture

attach_file Other
attach_file Society
attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Society
attach_file Other
attach_file Economics
attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Other


ID: 2568423405
Add Watch Country

arrow_drop_down